Overview
I am a Research Technician based in the Division of Cancer & Genetics at the School of Medicine
I am responsible for patient samples coming into the AML clinical trials (Acute Myeloid Leukaemia), funded by ECMC
I have a wide portofio of research experience having worked in R and D in Industry and Academic establishments.
Publication
2020
- Alanazi, B. et al. 2020. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34 (2), pp.427-440. (10.1038/s41375-019-0596-4)
2012
- Forrest, M. et al. 2012. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Human Mutation 33 (12), pp.1676-1686. (10.1002/humu.22160)
Articles
- Alanazi, B. et al. 2020. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34 (2), pp.427-440. (10.1038/s41375-019-0596-4)
- Forrest, M. et al. 2012. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome. Human Mutation 33 (12), pp.1676-1686. (10.1002/humu.22160)